AlphaMol is an AI-based bio-pharmaceutical company focusing on G protein-coupled receptor drug discovery. The Cofounders of AlphaMol are leading scientists in the area of GPCRs. Many essential molecular mechanisms and biotechnology were invented by the members of AlphaMol.
Cooperation possibilities
- license out our GPCR asset
- Co-development for GPCR drug discovery
- Computational platform for GPCR drug discovery
Some insights
- Accurate platform for GPCR drug discovery
- Biochips for GPCR biological testing in physiological condition
Defeated Google's AlphaFold2 in the Global GPCR-DOCK 2021 contest with 60% higher accuracy.